CD274 and neoplasm: PD-L1-positivity is defined as PD-L1-expressing tumor-infiltrating immune cells covering at least 1% of the tumor area [56], and thus neoadjuvant atezolizumab combined with chemotherapy is recommended for these patients [57, 58].